Viewing Study NCT02452268


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-29 @ 5:59 PM
Study NCT ID: NCT02452268
Status: TERMINATED
Last Update Posted: 2023-03-03
First Post: 2015-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module